Arrowhead Pharmaceuticals (ARWR) News Today $29.42 +0.75 (+2.62%) Closing price 04:00 PM EasternExtended Trading$29.00 -0.42 (-1.41%) As of 06:03 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock ARWR Latest News All Sources Trusted Sources MarketBeat Barchart Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent September 2025 August 2025 July 2025 June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 Time Period Arrowhead Pharmaceuticals, Inc. $ARWR Shares Sold by Rhumbline AdvisersSeptember 16 at 3:49 AM | marketbeat.comUBS AM A Distinct Business Unit of UBS Asset Management Americas LLC Purchases 2,774,933 Shares of Arrowhead Pharmaceuticals, Inc. $ARWRSeptember 16 at 3:06 AM | marketbeat.comWoodline Partners LP Has $7.16 Million Stake in Arrowhead Pharmaceuticals, Inc. $ARWRSeptember 15 at 4:00 AM | marketbeat.comArrowhead Pharmaceuticals (NASDAQ:ARWR) Trading 4.3% Higher - Should You Buy?September 14 at 1:21 PM | marketbeat.comCantor Fitzgerald Brokers Cut Earnings Estimates for ARWRSeptember 14 at 6:34 AM | marketbeat.comFY2025 EPS Estimates for ARWR Lowered by Cantor FitzgeraldSeptember 14 at 2:29 AM | americanbankingnews.comArrowhead Pharmaceuticals (NASDAQ:ARWR) Sets New 1-Year High - What's Next?September 13 at 5:51 PM | marketbeat.comBank of America Securities Sticks to Its Buy Rating for Arrowhead Pharmaceuticals (ARWR)September 13 at 3:53 AM | theglobeandmail.comArrowhead Pharmaceuticals Faces Patent Lawsuit from IonisSeptember 13 at 3:53 AM | msn.comIonis, Arrowhead file dueling patent lawsuits over genetic-disorder drugSeptember 11, 2025 | reuters.comArrowhead Pharmaceuticals Files Complaint for Declaratory Judgment Against Ionis PharmaceuticalsSeptember 11, 2025 | businesswire.comArrowhead Pharmaceuticals, Inc. (ARWR) Presents At Morgan Stanley 23rd Annual Global Healthcare Conference TranscriptSeptember 10, 2025 | seekingalpha.comH.C. Wainwright Reiterated a Buy on Arrowhead Pharmaceuticals (ARWR)September 10, 2025 | insidermonkey.comArrowhead Pharmaceuticals, Inc. (ARWR) Presents At H.C. Wainwright 27th Annual Global Investment Conference TranscriptSeptember 9, 2025 | seekingalpha.comArrowhead Pharmaceuticals, Inc. $ARWR Shares Sold by Corebridge Financial Inc.September 9, 2025 | marketbeat.comArrowhead Pharmaceuticals, Inc. $ARWR Shares Sold by MetLife Investment Management LLCSeptember 8, 2025 | marketbeat.comHsbc Holdings PLC Acquires Shares of 13,850 Arrowhead Pharmaceuticals, Inc. $ARWRSeptember 8, 2025 | marketbeat.comArrowhead Pharmaceuticals, Inc. (ARWR) Presents At Cantor Global Healthcare Conference 2025 TranscriptSeptember 7, 2025 | seekingalpha.comEquities Analysts Set Expectations for ARWR FY2026 EarningsSeptember 7, 2025 | marketbeat.comFY2025 Earnings Estimate for ARWR Issued By Zacks Small CapSeptember 7, 2025 | marketbeat.comRussell Investments Group Ltd. Cuts Stake in Arrowhead Pharmaceuticals, Inc. $ARWRSeptember 7, 2025 | marketbeat.comEquities Analysts Offer Predictions for ARWR FY2026 EarningsSeptember 7, 2025 | americanbankingnews.comZacks Small Cap Issues Negative Forecast for ARWR EarningsSeptember 6, 2025 | americanbankingnews.comArrowhead Pharmaceuticals (NASDAQ:ARWR) Hits New 52-Week High - Still a Buy?September 5, 2025 | marketbeat.comArrowhead Pharmaceuticals (NASDAQ:ARWR) Insider James Hamilton Sells 15,000 SharesSeptember 5, 2025 | insidertrades.comArrowhead Pharmaceuticals (NASDAQ:ARWR) Trading Up 11% - Here's WhySeptember 4, 2025 | marketbeat.comHC Wainwright Reaffirms Buy Rating for Arrowhead Pharmaceuticals (NASDAQ:ARWR)September 4, 2025 | marketbeat.comADAR1 Capital Management LLC Boosts Stock Holdings in Arrowhead Pharmaceuticals, Inc. $ARWRSeptember 4, 2025 | marketbeat.comNorthern Trust Corp Sells 273,606 Shares of Arrowhead Pharmaceuticals, Inc. $ARWRSeptember 4, 2025 | marketbeat.comArrowhead Pharmaceuticals, Inc. (ARWR) Presents At Citi's 2025 Biopharma Back To School Conference (Transcript)September 3, 2025 | seekingalpha.comArrowhead: Upcoming Plozasiran PDUFA Review Date And Subsequent Expansion In PlaceSeptember 3, 2025 | seekingalpha.comArrowhead Pharma Jumps After Inking A Deal Worth Up To $2.2 BillionSeptember 3, 2025 | msn.comArrowhead Pharmaceuticals and Novartis sign global deal for siRNA therapySeptember 3, 2025 | msn.comArrowhead Pharmaceuticals stock surges on $200 million Novartis dealSeptember 2, 2025 | in.investing.comARWR: Signs Collaboration Agreement with Novartis with $200 Million Upfront…September 2, 2025 | finance.yahoo.comArrowhead Pharmaceuticals and Novartis Enter into a Global License and Collaboration AgreementSeptember 2, 2025 | businesswire.comMagnetar Financial LLC Buys 56,008 Shares of Arrowhead Pharmaceuticals, Inc. $ARWRSeptember 2, 2025 | marketbeat.comRafferty Asset Management LLC Acquires 54,414 Shares of Arrowhead Pharmaceuticals, Inc. $ARWRSeptember 2, 2025 | marketbeat.comArrowhead Pharmaceuticals, Inc. (NASDAQ:ARWR) institutional owners may be pleased with recent gains after 7.6% loss over the past yearSeptember 1, 2025 | finance.yahoo.comJump Financial LLC Sells 52,755 Shares of Arrowhead Pharmaceuticals, Inc. $ARWRSeptember 1, 2025 | marketbeat.comSiren L.L.C. Has $34.01 Million Stock Holdings in Arrowhead Pharmaceuticals, Inc. $ARWRAugust 31, 2025 | marketbeat.comTema Etfs LLC Decreases Stake in Arrowhead Pharmaceuticals, Inc. $ARWRAugust 31, 2025 | marketbeat.comInvesco Ltd. Purchases 137,845 Shares of Arrowhead Pharmaceuticals, Inc. $ARWRAugust 31, 2025 | marketbeat.comNuveen LLC Takes $4.31 Million Position in Arrowhead Pharmaceuticals, Inc. $ARWRAugust 29, 2025 | marketbeat.comHighTower Advisors LLC Has $1.43 Million Stock Position in Arrowhead Pharmaceuticals, Inc. $ARWRAugust 28, 2025 | marketbeat.comArrowhead Pharmaceuticals to Participate in Upcoming September 2025 ConferencesAugust 27, 2025 | mms.businesswire.comArrowhead Pharmaceuticals to Participate in Upcoming September 2025 ConferencesAugust 27, 2025 | businesswire.comCapital Fund Management S.A. Makes New $2.08 Million Investment in Arrowhead Pharmaceuticals, Inc. $ARWRAugust 27, 2025 | marketbeat.comPale Fire Capital SE Takes Position in Arrowhead Pharmaceuticals, Inc. $ARWRAugust 26, 2025 | marketbeat.comT. Rowe Price Investment Management Inc. Raises Stock Position in Arrowhead Pharmaceuticals, Inc. $ARWRAugust 26, 2025 | marketbeat.com Get Arrowhead Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for ARWR and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. ARWR Media Mentions By Week ARWR Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. ARWR News Sentiment▼0.550.92▲Average Medical News Sentiment ARWR News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. ARWR Articles This Week▼167▲ARWR Articles Average Week Get the Latest News and Ratings for ARWR and Related Stocks Enter your email address to receive the latest news and analysts' ratings for Arrowhead Pharmaceuticals and its competitors. Sign Up View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. Related Companies and Tools Related Companies Summit Therapeutics News Ascendis Pharma A/S News Viatris News Dr. Reddy's Laboratories News Qiagen News BridgeBio Pharma News Moderna News Elanco Animal Health News Verona Pharma PLC American Depositary Share News Roivant Sciences News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:ARWR) was last updated on 9/16/2025 by MarketBeat.com Staff From Our PartnersFanatics Hit $31B-Is This Nasdaq Next?Fanatics built an empire by owning the fan experience-scaling to a $31B valuation. But the next wave isn't abo...i2i Marketing Group, LLC | SponsoredWhy More Investors Are Using Family Trusts to Protect Their WealthFor many investors, a family trust can be an essential tool for protecting assets, avoiding probate, and ensur...SmartAsset | SponsoredBuffett, Gates and Bezos Quietly Dumping Stocks—Here's WhyImagine a bull market so powerful, every single investor became a millionaire. Not by finding the next NVIDIA ...Banyan Hill Publishing | Sponsored$3,600 gold is nice ... but here’s what most gold bugs are missingGold just surged past $3,600, but Weiss Ratings expert Sean Brodrick says the real upside is in select gold st...Weiss Ratings | SponsoredFree: The Crypto Summit That Could Change Your LifeWall Street’s Crypto Playbook—Revealed at This Free Event If you want to understand what's really happening...Crypto 101 Media | SponsoredForget NVDA. Put $1,000 into this stock nowA massive money shift is underway in the AI market. And it's opening up an extraordinary opportunity in a NEW ...Chaikin Analytics | SponsoredIRS Wants Another Check on Sept 15th—What If You Could Keep It Instead?On September 15th, the IRS collects another round of quarterly tax payments—targeting self-employed profession...American Alternative | SponsoredOpenAI’s new $300 billion dealOpenAI just signed a $300 billion cloud deal with Oracle to secure the computing power needed for its next Cha...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Arrowhead Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Arrowhead Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free ARWR Stock Alerts